Peers “would highly recommend” Jeny Maier as a "great competition lawyer with strong expertise in merger cases". Her practice specialises in advising on the antitrust requirements of large international M&A matters.
Jeny Maier has comprehensive experience advising clients in all facets of antitrust law. She regularly advises parties to large, strategic M&A transactions on international antitrust notification requirements and substantive competition issues.
Recent representative M&A experience includes securing unconditional clearance from the US Department of Justice for McKesson's US$3.4 billion healthcare technology joint venture with Change Healthcare; assisting Dell in achieving clearance in 18 jurisdictions around the world in its US$67 billion acquisition of EMC; representing Johnson Controls International in the US$2 billion sale of its Scott Safety business to 3M and securing clearance for Stanley Black & Decker in its US$900 million purchase of the Craftsman brand from Sears Holdings.
Jeny also has considerable experience assisting clients with responding to civil and criminal antitrust investigations and defending class-action litigation. In addition to M&A and litigation, Jeny counsels clients on a broad range of antitrust issues relating to pricing practices, distribution and marketing arrangements, intellectual property licence agreements and standard-setting activities.
In her years of practice, she has worked closely with clients across a broad range of industries, with particular experience in the technology, telecommunications, transportation, healthcare and pharmaceutical fields.
Before joining Axinn, Jeny spent 10 years in the antitrust practice of a large, global law firm. Prior to that, she served as a legal intern for the Federal Trade Commission, Bureau of Competition and for the US Department of Justice Antitrust Division (National Criminal Enforcement Section).
Jeny was previously named a "bright rising star" in the area of antitrust law by The Legal 500. She serves on the editorial board of the ABA Antitrust Section’s annual Antitrust Law Developments publication. Jeny also regularly contributes on publications and speaking engagements on antitrust issues for the American Health Lawyers Association.